Detalhe da pesquisa
1.
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group.
Ann Rheum Dis
; 80(2): 242-249, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33055082
2.
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group.
Ann Rheum Dis
; 79(10): 1269-1276, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32606042
3.
Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients.
J Clin Rheumatol
; 25(3): e8-e11, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29683839
4.
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Lancet
; 388(10042): 343-355, 2016 Jul 23.
Artigo
Inglês
| MEDLINE | ID: mdl-27287832
5.
Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review.
Rheumatology (Oxford)
; 56(7): 1177-1188, 2017 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28398508
6.
Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.
Ann Rheum Dis
; 73(10): 1781-7, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23852690
7.
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study.
Ann Rheum Dis
; 72(11): 1800-5, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23178206
8.
Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 52(10): 1809-17, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23813577
9.
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
Semin Arthritis Rheum
; 63: 152288, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37918049
10.
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.
Ann Rheum Dis
; 71(11): 1855-60, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22772326
11.
'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought.
Rheumatology (Oxford)
; 51(1): 69-76, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21565901
12.
Optimizing Reliability of Real-Time Sonographic Examination and Scoring of Joint Synovitis in Rheumatoid Arthritis.
Cureus
; 14(11): e31030, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36475184
13.
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group.
Semin Arthritis Rheum
; 51(3): 607-617, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33483129
14.
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.
Semin Arthritis Rheum
; 51(3): 601-606, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33875246
15.
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.
Lancet
; 371(9617): 987-97, 2008 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-18358926
16.
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World Use.
Drug Saf
; 42(12): 1499-1506, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31696432
17.
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.
J Rheumatol
; 46(9): 1173-1178, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31043547
18.
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.
J Rheumatol
; 46(9): 1159-1163, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30647174
19.
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial.
Lancet Rheumatol
; 1(3): e145-e153, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38229391
20.
Scleroderma renal crisis and renal involvement in systemic sclerosis.
Nat Rev Nephrol
; 14(2): 137, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29292373